Live
PolicyWhite House AI health initiative targets access gaps in underserved communitiesLillyLillyDirect Employer Connect launches nationwide — March 2026ScienceNEJM: AI-assisted diagnosis cuts dementia detection wait times by 40%AILilly × NVIDIA $1B AI supercomputer now operational for molecular simulationPolicyCMS expands telehealth reimbursement for chronic disease — Q1 2026Access7M Americans with Alzheimer's — majority without a formal diagnosisLillyLilly projects $80–83B revenue for 2026 on GLP-1 and Alzheimer's momentumAIOpenAI × Lilly collaboration targets patient communication and adherenceScienceFDA approves first AI-powered clinical decision tool for early dementia diagnosisPolicyIRA drug pricing negotiations reshape pharma commercial strategyAINVIDIA CEO: healthcare is the single largest AI opportunity in the next decadeAccessRural patients drive 50+ miles one-way for neurology access — JAGS 2024ScienceTirzepatide: 22% sustained weight reduction at 72 weeks — SURMOUNT-4 final dataLillyKisunla approved for early symptomatic Alzheimer's — reshaping the diagnostic windowPolicyHHS announces AI accountability framework for patient-facing digital health toolsPolicyWhite House AI health initiative targets access gaps in underserved communitiesLillyLillyDirect Employer Connect launches nationwide — March 2026ScienceNEJM: AI-assisted diagnosis cuts dementia detection wait times by 40%AILilly × NVIDIA $1B AI supercomputer now operational for molecular simulationPolicyCMS expands telehealth reimbursement for chronic disease — Q1 2026Access7M Americans with Alzheimer's — majority without a formal diagnosisLillyLilly projects $80–83B revenue for 2026 on GLP-1 and Alzheimer's momentumAIOpenAI × Lilly collaboration targets patient communication and adherenceScienceFDA approves first AI-powered clinical decision tool for early dementia diagnosisPolicyIRA drug pricing negotiations reshape pharma commercial strategyAINVIDIA CEO: healthcare is the single largest AI opportunity in the next decadeAccessRural patients drive 50+ miles one-way for neurology access — JAGS 2024ScienceTirzepatide: 22% sustained weight reduction at 72 weeks — SURMOUNT-4 final dataLillyKisunla approved for early symptomatic Alzheimer's — reshaping the diagnostic windowPolicyHHS announces AI accountability framework for patient-facing digital health tools

Extraordinary medicines.

An ordinary experience
of receiving them.

A design perspective on the distance between what Eli Lilly's science makes possible and what patients actually experience.

Jeremy Grant · Design Director · March 2026